Three Hot Topics from ADA 2024

Three Hot Topics from ADA 2024

Biotech takes on chronic weight management As Novo Nordisk and Lilly generate massive profits with weight-loss blockbusters Wegovy and Zepbound, several smaller players are looking to develop novel solutions that address some of the challenges with currently marketed...
Top News from Biggest Players at ASCO 2024

Top News from Biggest Players at ASCO 2024

ASCO 2024 ran from May 31-June 4 in Chicago, IL, bringing together physicians, academics, and industry to share data and discuss cutting edge treatments in oncology. Below, Adelphi’s Oncology Task Force breaks down key news from some of the biggest players in...
Continuing to Drive Change in 2024

Continuing to Drive Change in 2024

As we enter a new year, our end goal remains the same – to inspire action and drive change. We are always on the lookout for ways to enhance the insights we bring to our clients, whether we are using innovative technology with agility, understanding behaviour, or...
Adelphi Attends Trio Of Exciting Conferences

Adelphi Attends Trio Of Exciting Conferences

Over the last few months our team has been busy attending a range of interesting conferences to discuss all things innovation and healthcare research. We’ve attended conferences by some of the most interesting voices in the industry, including Intellus, JP Morgan...